Tramadol Hcl Tablet, Extended Release
Product Images NDC 80425-0108

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tramadol Hcl (NDC 80425-0108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

A line chart comparing plasma concentration of Tramadol over 24 hours after administration of Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The y-axis represents Tramadol concentration in ng/mL and the x-axis shows time in hours, illustrating differences in drug concentration profiles between the two dosage forms.*

FDA Label Image

Fig 2

A line graph depicting M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily and Tramadol Hydrochloride Tablets 50 mg taken every 6 hours. The x-axis shows time in hours, the y-axis shows M1 concentration, and two lines represent the concentration profiles for the two formulations.*

FDA Label Image

Fig 3

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' illustrating the percent of patients achieving response at various thresholds of percent improvement from baseline. It compares response rates for Tramadol Hydrochloride Extended-Release Tablets at doses of 100 mg, 200 mg, 300 mg, and 400 mg versus placebo across response thresholds from 0% to 100%. The 100 mg dose consistently shows the highest percent of patients achieving response, followed by higher doses and placebo with the lowest response rates.*

FDA Label Image

Fig 4

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis.' It shows the percent of patients achieving various levels of response threshold (percent improvement from baseline) on the X-axis and percent of patients achieving response on the Y-axis. Two lines compare Tramadol Hydrochloride Extended-Release Tablets versus placebo, illustrating a higher percentage of patients achieving response at each threshold with the active drug compared to placebo.*

FDA Label Image

Structure

Chemical structure of tramadol hydrochloride showing its distinct aromatic ring with a methoxy group, a cyclohexane ring, and an aminoethyl side chain, consistent with the active ingredient in Tramadol HCL ER 100 mg tablets.*

FDA Label Image

Tramadol HCl Er 100mg Qty 30 Ndc 80425 0108

Packaging label for Tramadol HCL ER 100 mg extended-release tablets, #30 count. The label shows the product name prominently with dosing strength and tablet form. It is labeled by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN. The label includes NDC 80425-0108-01 and batch information. Storage is recommended at 20°-25°C (68°-77°F).*

FDA Label Image

Tramadol HCl Er 100mg Qty 60 Ndc 80425 0108

Label for Tramadol HCL ER 100 mg extended release tablets, 60 count, manufactured by Advanced Rx Pharmacy of Tennessee, LLC. Includes comparison to Ultram ER and supply details like NDC 80425-0108, lot number, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.